RU2006119329A - Комбинации ат1-антагонистов, амилорида или триаметерина, и диуретика - Google Patents
Комбинации ат1-антагонистов, амилорида или триаметерина, и диуретика Download PDFInfo
- Publication number
- RU2006119329A RU2006119329A RU2006119329/15A RU2006119329A RU2006119329A RU 2006119329 A RU2006119329 A RU 2006119329A RU 2006119329/15 A RU2006119329/15 A RU 2006119329/15A RU 2006119329 A RU2006119329 A RU 2006119329A RU 2006119329 A RU2006119329 A RU 2006119329A
- Authority
- RU
- Russia
- Prior art keywords
- hypertension
- pharmaceutically acceptable
- acceptable salt
- diuretic
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/549—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Urology & Nephrology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0325605.4A GB0325605D0 (en) | 2003-11-03 | 2003-11-03 | Combination of organic compounds |
| GB0325605.4 | 2003-11-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006119329A true RU2006119329A (ru) | 2007-12-27 |
Family
ID=29725841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006119329/15A RU2006119329A (ru) | 2003-11-03 | 2004-11-02 | Комбинации ат1-антагонистов, амилорида или триаметерина, и диуретика |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20070072848A1 (https=) |
| EP (1) | EP1682122B9 (https=) |
| JP (1) | JP2007509900A (https=) |
| KR (1) | KR20060097025A (https=) |
| CN (1) | CN1878548A (https=) |
| AT (1) | ATE389399T1 (https=) |
| AU (1) | AU2004290505B2 (https=) |
| BR (1) | BRPI0416154A (https=) |
| CA (1) | CA2544230A1 (https=) |
| DE (1) | DE602004012593T2 (https=) |
| ES (1) | ES2303958T3 (https=) |
| GB (1) | GB0325605D0 (https=) |
| PL (1) | PL1682122T3 (https=) |
| PT (1) | PT1682122E (https=) |
| RU (1) | RU2006119329A (https=) |
| WO (1) | WO2005049013A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090062309A1 (en) * | 2007-08-28 | 2009-03-05 | Antonio Delgado-Almeida | Therapeutic compositions for the treatment of cardiovascular diseases and methods for use therefor |
| WO2012152718A1 (en) | 2011-05-06 | 2012-11-15 | Farmicom Pharmaceutical Company D.O.O. | Composition comprising angiotensin ii receptor antagonist and antioxidant for maintaining and/or improving skin properties |
| CN102793703A (zh) * | 2011-05-25 | 2012-11-28 | 苏州洪瑞医药科技有限公司 | 一种盐酸阿米洛利和环戊噻嗪的药物组合物及其制备方法 |
| WO2018027550A1 (en) * | 2016-08-09 | 2018-02-15 | Shanghai Yao Yuan Biotechnology Co., Ltd. | Methods and compositions for appetite control and weight management |
| CN109364248B (zh) * | 2018-10-16 | 2021-05-18 | 哈尔滨医科大学 | ENaC及其抑制剂在预防、缓解和/或治疗动脉粥样硬化中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4898729A (en) * | 1983-12-09 | 1990-02-06 | Euroceltique, S.A. | Treatment of hypertension, compounds and compositions for antihypertension and diuresis |
| GB9613470D0 (en) * | 1996-06-27 | 1996-08-28 | Ciba Geigy Ag | Small solid oral dosage form |
| US6323226B1 (en) * | 1999-10-19 | 2001-11-27 | Texas Heart Institute | Treatment of heart disease with cox-2 inhibitors |
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| US20040087484A1 (en) * | 2000-12-01 | 2004-05-06 | Sahota Pritam Singh | Combination of organic compounds |
| EG24716A (en) * | 2002-05-17 | 2010-06-07 | Novartis Ag | Combination of organic compounds |
-
2003
- 2003-11-03 GB GBGB0325605.4A patent/GB0325605D0/en not_active Ceased
-
2004
- 2004-02-11 US US10/577,370 patent/US20070072848A1/en not_active Abandoned
- 2004-11-02 DE DE602004012593T patent/DE602004012593T2/de not_active Revoked
- 2004-11-02 CA CA002544230A patent/CA2544230A1/en not_active Abandoned
- 2004-11-02 BR BRPI0416154-8A patent/BRPI0416154A/pt not_active IP Right Cessation
- 2004-11-02 WO PCT/EP2004/012386 patent/WO2005049013A1/en not_active Ceased
- 2004-11-02 KR KR1020067008517A patent/KR20060097025A/ko not_active Withdrawn
- 2004-11-02 JP JP2006537238A patent/JP2007509900A/ja active Pending
- 2004-11-02 EP EP04797529A patent/EP1682122B9/en not_active Revoked
- 2004-11-02 CN CNA2004800329189A patent/CN1878548A/zh active Pending
- 2004-11-02 PL PL04797529T patent/PL1682122T3/pl unknown
- 2004-11-02 PT PT04797529T patent/PT1682122E/pt unknown
- 2004-11-02 ES ES04797529T patent/ES2303958T3/es not_active Expired - Lifetime
- 2004-11-02 RU RU2006119329/15A patent/RU2006119329A/ru not_active Application Discontinuation
- 2004-11-02 AT AT04797529T patent/ATE389399T1/de not_active IP Right Cessation
- 2004-11-02 AU AU2004290505A patent/AU2004290505B2/en not_active Ceased
-
2008
- 2008-09-26 US US12/286,039 patent/US20090036432A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE389399T1 (de) | 2008-04-15 |
| AU2004290505A1 (en) | 2005-06-02 |
| ES2303958T3 (es) | 2008-09-01 |
| PL1682122T3 (pl) | 2008-09-30 |
| AU2004290505B2 (en) | 2007-09-20 |
| DE602004012593D1 (de) | 2008-04-30 |
| CN1878548A (zh) | 2006-12-13 |
| GB0325605D0 (en) | 2003-12-10 |
| EP1682122B1 (en) | 2008-03-19 |
| US20070072848A1 (en) | 2007-03-29 |
| WO2005049013A1 (en) | 2005-06-02 |
| CA2544230A1 (en) | 2005-06-02 |
| BRPI0416154A (pt) | 2007-01-09 |
| EP1682122A1 (en) | 2006-07-26 |
| EP1682122B9 (en) | 2009-04-08 |
| DE602004012593T2 (de) | 2009-04-23 |
| KR20060097025A (ko) | 2006-09-13 |
| US20090036432A1 (en) | 2009-02-05 |
| PT1682122E (pt) | 2008-06-18 |
| JP2007509900A (ja) | 2007-04-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111405899B (zh) | 用于治疗内皮素相关疾病的4-嘧啶磺酰胺衍生物与sglt-2抑制剂的组合 | |
| RU2006132668A (ru) | Синергетические комбинации, которые содержат ингибитор ренина, предназначенные для лечения сердечно-сосудистых заболеваний | |
| CA2904447C (en) | Therapy for complications of diabetes | |
| HRP20200828T1 (hr) | Farmaceutski pripravak koji sadrži sglt2-inhibitor, dpp-iv-inhibitor i prema potrebi jedno dodatno antidijabetičko sredstvo, te njegove uporabe | |
| RU2004139025A (ru) | Комбинация ингибитора дипептидилпептидазы iv (dpp iv) и сердечно-сосудистого вещества | |
| JP2005533023A5 (https=) | ||
| RU2003116896A (ru) | Синергетические композиции, которые содержат ингибитор ренина, предназначенные для лечения сердечно-сосудистых заболеваний | |
| RU2005128124A (ru) | Фармацевтические препараты и их применение для профилактики удара, диабета и/или застойной сердечной недостаточности | |
| JP2010536880A5 (https=) | ||
| RU2002129569A (ru) | Новое медицинское применение ингибиторов альдостеронсинтазы индивидуально или в сочетании с антагонистами ат1-рецептора | |
| JP2015205909A (ja) | 組合せ | |
| RU2009110452A (ru) | Галеновые составы алискирена | |
| EP1569682A2 (en) | Combination treatment using exendin-4 and thiazolidinediones | |
| EP1587479B1 (de) | Pharmazeutische kombination zur prophylaxe oder therapie von kardiovaskulären, kardiopulmonalen, pulmonalen oder renalen krankheiten | |
| JPWO2011002001A1 (ja) | ピラゾール誘導体とビグアナイド薬との組み合わせ医薬 | |
| RU2006119329A (ru) | Комбинации ат1-антагонистов, амилорида или триаметерина, и диуретика | |
| RU2006122637A (ru) | Производные 4-фенилпиперидина в качестве ингибиторов ренина | |
| CA2605847C (en) | Ddp-iv inhibitors for the treatment of postprandial hyperlipidemia | |
| EP1818056A1 (de) | Pharmazeutische Kombination zur Prophylaxe oder Therapie von kardiovaskulären, kardiopulmonalen, pulmonalen oder renalen Krankheiten | |
| Davoren | Glucose-lowering medicines for type 2 diabetes | |
| JP2007509900A5 (https=) | ||
| Silverstein et al. | Angiotensin-receptor blockers: benefits beyond lowering blood pressure | |
| JP2003335678A (ja) | 神経因性疼痛治療薬 | |
| Mpe | Choosing antihypertensive treatment for a South African population | |
| CN119255805A (zh) | 用于治疗高血压的阿普昔腾坦 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20091109 |